MedPath

PVP Iodine vs Chlorhexidine in Alcohol for Disinfection of the Surgical Site

Phase 4
Completed
Conditions
Surgical Site Infections
Interventions
Drug: PI Disinfection
Drug: CHX disinfection
Registration Number
NCT03685604
Lead Sponsor
University Hospital, Basel, Switzerland
Brief Summary

Prospective cluster-randomized multicenter cross-over trial to prove non-inferiority of PI compared to CHX in preoperative skin antisepsis

Detailed Description

Surgical site infections (SSIs) are the most common nosocomial infections in surgical patients causing significant increases in morbidity, mortality, and health care costs. As they are usually caused by components of the normal skin flora, disinfection of the surgical site with an antiseptic skin preparation is standard practice prior to any surgical intervention. The most commonly used disinfectants are either chlorhexidine in alcoholic solution (CHX) or PVP iodine in alcoholic solution (PI) This prospective cluster-randomized multicenter cross-over trial is to prove non-inferiority of PI compared to CHX in preoperative skin antisepsis in abdominal and cardiothoracic surgery in regard of SSIs.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3321
Inclusion Criteria
  • undergoing cardiac or certain types of abdominal surgery (colorectal surgery, cholecystectomy, herniotomy, appendectomy and bariatric surgery) which are routinely followed up by the study Centers during the study period
Exclusion Criteria
  • contraindication to the use of either one of the compounds ( CHX: intolerance to any of the compounds of the preparation, application on cornea, wounds or mucosal Membrane. PI: hyperthyroid disease, intolerance to any of the compounds, iodine allergy, 2 weeks prior to radio- iodine treatment, Dermatitis herpetiformis Duhring, application on cornea, wounds or mucosal membranes)
  • Emergency surgical Intervention
  • Patients refusing General consent for use of personal data

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cardiothoracic surgery - PI disinfectionPI Disinfection-
Cardiothoracic surgery - CHX disinfectionCHX disinfection-
Abdominal surgery - PI disinfectionPI Disinfection-
Abdominal surgery - CHX disinfectionCHX disinfection-
Primary Outcome Measures
NameTimeMethod
Surgical site infections (SSIs)occurrence of surgical site infections is evaluated at three time points: at time of dismissal from the hospital (approx. 1 week after surgical intervention); 30 days after abdominal and cardiac surgery; 1 year for cardiac surgery

Comparison of SSI rates between the two groups using standard chi-square test. Presence of SSIs for abdominal and cardiac surgeries as defined by Swiss society of hospital epidemiologists (Swissnoso) according to National Healthcare Safety Network (NHSN) criteria. Analysis will be performed using the final SSI rate (30 days for abdominal, 30 days/1 year for cardiac surgery) and according to the different types of infections. Infection ratio will be calculated as crude ratio as well as adapted to the National Nosocomial Infections Surveillance System (NNIS) score. The method of aggregation for the combined SSI rate for both types of surgery together will be a weighted average based on the proportion of SSIs from each surgery type. The measure includes no scale.

Secondary Outcome Measures
NameTimeMethod
American Society of Anesthesiologists (ASA) -scoreday of surgery

ASA physical status classification system is a system for assessing the fitness of patients before surgery. These are:

1. Healthy person.

2. Mild systemic disease.

3. Severe systemic disease.

4. Severe systemic disease that is a constant threat to life.

5. A moribund person who is not expected to survive without the operation.

6. A declared brain-dead person whose organs are being removed for donor purposes.

Body Mass Index (BMI)day of surgery

Subgroup analysis stratified by patient factors (i.e. BMI). Weight and height will be combined to report BMI in kg/m\^2).

Mortalityin-hospital (approx. 1 week from surgical intervention) and 30 day for abdominal surgery; in-hospital (approx. 1 week from surgical intervention), 30 day and 365 day for cardiac surgery

death rate

Change in creatinine (ymol/l)in- hospital stay (approx. 1 week from surgical intervention)

Subgroup analysis stratified by laboratory parameters: creatinine (ymol/l)

National Nosocomial Infections Surveillance System (NNIS) indexin- hospital stay (approx. 1 week from surgical intervention)

NNIS index takes into account 3 risk factors, and each is awarded 1 point: contaminated or dirty-infected surgical wound, American Society of Anesthesiology (ASA) score greater than 2 and surgery duration longer than T (where T is defined as the 75th percentile of the average time for a surgical procedure).

Change in leukocytes (x10^9/l)in- hospital stay (approx. 1 week from surgical intervention)

Subgroup analysis stratified by laboratory parameters: leukocytes (x10\^9/l)

Change in hemoglobin (g/l)day of surgery

Subgroup analysis stratified by laboratory parameters: hemoglobin (g/l)

Timing of antimicrobial prophylaxisday of surgery

Timing of antimicrobial prophylaxis (antibiotic, dose,time of application)

Type of SSI: superficial, deep, organ-spacethree time points: at time of dismissal from the hospital (approx. 1 week after surgical intervention); 30 days after abdominal and cardiac surgery; 1 year for cardiac surgery

Type of SSI: superficial, deep, organ-space; DEFINITIONS OF SSI: For surveillance classification purposes, SSIs are divided into incisional SSIs and organ/space SSIs. Incisional SSIs are further classified into those involving only the skin and subcutaneous tissue (called superficial incisional SSIs) and those involving deep soft tissues of the incision (called deep incisional SSIs (e.g., fascial and muscle layers)). Organ/space SSIs involve any part of the anatomy (e.g., organs or spaces), other than the incision, opened or manipulated during the operative procedure.

Duration of surgerytime from start to stop of surgical intervention

Duration of surgery

Wound contamination -class according to Centers for Disease Control and Prevention(CDC)three time points: at time of dismissal from the hospital (approx. 1 week after surgical intervention); 30 days after abdominal and cardiac surgery; 1 year for cardiac surgery

Wound contamination -class according to Centers for Disease Control and Prevention(CDC)

Change in concentration for C reactive Protein (CRP) (mg/l)in- hospital stay (approx. 1 week from surgical intervention)

Subgroup analysis stratified by laboratory parameters: CRP (mg/l)

Trial Locations

Locations (3)

University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology

🇨🇭

Basel, Switzerland

University Hospital of Bern; Division of Infectious Diseases and Hospital Epidemiology

🇨🇭

Bern, Switzerland

University Hospital Zurich, Division of Infectious Diseases and Hospital Epidemiology

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath